An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00683462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Placebo
DRUG: AZD3480
DRUG: AZD3480

Sponsor

AstraZeneca

Collaborators

[object Object]